The FDA has approved a new drug for people exposed to measles and hepatitis A viruses. Drugmaker Grifols said GamaSTAN immune globulin is 80% to 90% effective in preventing hepatitis A infection when administered within two weeks of exposure.
Oxford researchers have advanced the feasibility of a universal flu vaccine in Nature Communications. Testing old vaccines, scientists were able to show that although exact flu strains vary by season, parts of the virus targeted by the immune system limit its evolution. Pressure to develop a universal vaccine increased as last year’s batch offered limited protection, contributing to more than 80,000 U.S. deaths.
Albuminuria, a biomarker associated with kidney disease, may also indicate lung problems such as COPD.
From the November 2018 Issue of McKnight's Long-Term Care News
